Jun 10, 2025
518:509
For every 509 shares held, investors received 518. The price per share adjusted from $1.89 to $1.86.
The split itself did not change the total investment value.
Crossject SA (GETTEX:74C) operates in the Medical specialties industry.
Crossject SA company overviewCrossject SA's most recent stock split was on June 10, 2025. It was a 518-for-509 forward split, so shareholders received 518 shares for every 509 they held.
Crossject SA (GETTEX:74C) has split its stock 3 times: a 524-for-521 split on October 6, 2022, a 917-for-909 split on May 14, 2024, and a 518-for-509 split on June 10, 2025.
Crossject SA has split its stock 3 times. This history records 3 forward splits between October 6, 2022 and June 10, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Crossject SA's 518-for-509 split on June 10, 2025, every 509 shares became 518 shares.
Crossject SA has not announced a new split in our records. Its most recent split was on June 10, 2025, 1 year ago. Companies announce splits in advance, and any new GETTEX:74C split will appear on this page.
Already premium?